Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
about
Final version of 2009 AJCC melanoma staging and classificationMultiple splice variants within the bovine silver homologue (SILV) gene affecting coat color in cattle indicate a function additional to fibril formation in melanophores.The efficient operation of the surgical pathology gross room.Histopathological mapping of metastatic tumor cells in sentinel lymph nodes of oral and oropharyngeal squamous cell carcinomas.Clinical and prognostic factors for melanoma of the skin using SEER registries: collaborative stage data collection system, version 1 and version 2.Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment.Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result.Sentinel lymph node biopsy for melanoma: indications and rationale.AJCC melanoma staging update: impact on dermatopathology practice and patient management.Clinically relevant information from sentinel lymph node biopsies of melanoma patients.Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate.Discordance in histopathologic evaluation of melanoma sentinel lymph node biopsy with clinical follow-up: results from a prospectively collected database.Sentinel lymph node biopsy for eyelid and conjunctival tumors: what is the evidence?Prevention of an additional surgery for regional lymphadenectomy in melanoma: rapid intraoperative immunostaining of sentinel lymph node imprint smears.Use of cytological samples of metastatic melanoma for ancillary studies.Overexpression of the anti-apoptotic protein BAG3 in human choroidal melanoma: A case report.Sentinel lymph node biopsy in malignant melanoma.Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up.Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution.A 10-year analysis of primary cutaneous malignant melanoma with sentinel lymph node biopsy and long-term follow-up.Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.Stage migration after minor changes in histologic estimation of tumor burden in sentinel lymph nodes: the protocol trap.
P2860
Q29614803-4FD7E06E-891C-437B-997D-BF36F38BF48DQ33300166-710B46EF-99E5-4B28-A0D1-D9FB21998689Q33993942-8D09B701-6889-483D-A2A0-E1B5169F16DAQ35180288-166921A8-0227-4421-9A6D-63C2EF7DA5B3Q35439967-89952883-D823-44DD-953F-6526C7B57AACQ37236435-B433F3AD-EB32-485C-BB2D-DDC6C9F364FCQ37375980-16A99643-DA5F-4776-A71A-B2A1251F6CDEQ37531858-07D9453F-9ACF-496F-AFCC-49A1ACD3FA09Q37850827-5CABC933-3575-478B-975F-FFC02BB475A0Q37920833-A619F07A-7294-4FA3-87A0-B53791CCAC20Q37920834-0E95FB74-7B73-4329-A3A4-11AF4D55C2C5Q38213235-F2E16593-E1B5-4B28-BFC3-AF9AF0551B88Q38273044-8FD57A02-FE88-4151-8057-6A7448759CB4Q38391707-8651645B-0B32-432E-9572-FC5E46CE98E5Q39144043-EFFD039E-4380-4EEC-9B92-668A79EFA5A4Q41820813-38E9D886-47E6-4E40-876F-86ADAF26E103Q43167662-FD5D4864-6D9B-483B-AA35-E337F2FC1FA8Q45074405-6A79200F-3A90-41E7-A912-B2D7C98DBBC6Q45180237-E3882B9F-72FF-49E6-B147-282C1C18B458Q47726575-834912B7-D973-4DC5-8868-240CB965C081Q49015294-D4691CDB-2A09-466D-B1B7-D4764861AE47Q52040414-3E6F69C8-6274-488C-B92D-EDBE0DC579E7Q53053538-26CF37AC-6A87-49BC-8676-05C6BB0382AA
P2860
Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Characterization of micrometas ...... dardizing pathologic analysis.
@ast
Characterization of micrometas ...... dardizing pathologic analysis.
@en
type
label
Characterization of micrometas ...... dardizing pathologic analysis.
@ast
Characterization of micrometas ...... dardizing pathologic analysis.
@en
prefLabel
Characterization of micrometas ...... dardizing pathologic analysis.
@ast
Characterization of micrometas ...... dardizing pathologic analysis.
@en
P2093
P1476
Characterization of micrometas ...... dardizing pathologic analysis.
@en
P2093
Daniel G Coit
David S Klimstra
Juan Rosai
Kathryn Spanknebel
Mithat Gonen
Samuel C Bieligk
P304
P356
10.1097/01.PAS.0000152134.36030.B7
P407
P577
2005-03-01T00:00:00Z